Exhibit 99.1  Gemini Therapeutics Reports Full Year 2020 Financial Results and Provides Business Update

| | - | *Business combination with FS Development Corp. resulted in new public listing, strengthened management team, and cash position of approximately $200 million* | | --- | --- | --- |

This is the opening of the release as filed. Read the full document on SEC.gov, or read it in full on SPAC Watch with the trust, deadline and warrant terms alongside it.